Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2024

The following table summarizes the Company’s net patient service revenue from continuing operations by service line (in percentages):


	Years Ended December 31,
	2024			2023			2022
Neonatology and other pediatric subspecialties		83	%		84	%		84	%
Maternal-fetal medicine		17	%		16	%		16	%
		100	%		100	%		100	%

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table presents information about the Company’s financial instruments that are accounted for at fair value on a recurring basis at December 31, 2024 and 2023 (in thousands):


		Fair Value
	Fair Value Category	December 31, 2024		December 31, 2023
Assets:
Money market funds	Level 1	$	9,295	$	2,814
Short-term investments	Level 2		118,566		104,485
Mutual funds	Level 1		18,581		17,687

Financial Instruments Measured At Carrying Amount

The following table presents information about the Company’s financial instruments that are not carried at fair value at December 31, 2024 and 2023 (in thousands):

           
          December 31, 2024

          December 31, 2023

           
          Carrying Amount

          Fair
Value

          Carrying Amount

          Fair
Value

          Liabilities:

2030 Notes

400,000

382,000

400,000

357,000

Pediatrix Medical Group, Inc. 10-K